North America Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by End-use, Method, GLP, Country and Growth Forecast, 2022-2028

The North America Toxicity Testing Outsourcing Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).

Initial toxicity testing frequently employs computer simulations (in silico) to forecast toxicokinetic routes or to forecast probable exposure spots by simulating weather patterns and water currents to identify the most vulnerable species or geographical areas. Microtox assays are another less time-consuming and more frequent test that monitors the development and production of bacteria.

This can be modified to measure photosynthesis rates and plant growth when exposed. Preclinical safety testing outsourcing or internal testing is a complex and multi-factor decision. Large firms could have the knowledge to carry out the necessary testing, but they don't have the resources. On the other hand, lab testing partners could offer priceless expertise and regulatory knowledge that speed up testing.

One of the most important factors that manufacturers must take into account is whether the testing-generated data will be thorough and reliable enough to satisfy regulators' requirements and result in a successful submission. Certain other factors that propel the trend of outsourcing toxicity testing are the lack of testing machines or cost constraints.

In North America, the regional market is expected to benefit from increased academic and government investment in genomics research and proteomics, as well as the creation of drug designs based on structure. The commercialization of portable toxicity testing equipment has provided significant opportunities for the expansion of toxicity testing. Due to the rising demand for speedy and precise results, particularly in forensic toxicology, many businesses are focusing on developing toxicity testing equipment.

The US market dominated the North America Toxicity Testing Outsourcing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,469.7 million by 2028.The Canada market is poised to grow at a CAGR of 9.8% during (2022-2028). Additionally, The Mexico market would witness a CAGR of 9.6% during (2022-2028).

Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes and Others. Based on Method, the market is segmented into In Vitro and In Vivo. Based on GLP, the market is segmented into GLP and Non-GLP. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific Group, WuXi AppTec Co., Ltd., SGS S.A., Intertek Group PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., ICON PLC, and Medpace Holdings, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End Use

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Others

By Method

• In Vitro
• In Vivo

By GLP

• GLP
• Non-GLP

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc.
• Eurofins Scientific Group
• WuXi AppTec Co., Ltd.
• SGS S.A.
• Intertek Group PLC
• Catalent, Inc.
• Laboratory Corporation of America Holdings
• Charles River Laboratories International, Inc.
• ICON PLC
• Medpace Holdings, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free